5 pediatric drug development tips to learn this quarter
Welcome to the Inner Circle!

5 pediatric drug development tips to learn this quarter

The evolution of the pediatric regulatory environment has increased the demand to develop a common scientific-based approach that is acceptable to global regulatory authorities. It is crucial to create a thoughtful plan to support efficient pediatric drug discovery and development to ensure safe and effective medicines for children.

Typical challenges encountered in a pediatric program include:

  • Enrollment challenges due to small populations and multiple sponsors targeting the same population
  • Burden of research procedures
  • Limitation in use of placebo and lack of active comparators
  • Physiological differences across the entire pediatric population
  • Bridging of knowledge from adults to pediatrics

Here are our top blogs, webinars, and videos to help set your pediatric program up for success!

No alt text provided for this image

INFOGRAPHIC:

Hot Topics in Pediatric Drug Development. In 2021, Certara hosted the inaugural New Horizons in Pediatric Drug Development symposium to bring together pediatric thought leaders and innovators to share new developments in the field and to collaborate on ideas to advance pediatric drug development. Here’s what we learned. Learn more.

No alt text provided for this image
No alt text provided for this image

BLOG:

Reflections on the Recent ICH E11A Pediatric Extrapolation Guideline. Three essential themes dictate the concepts in the recent guideline. Read more.

No alt text provided for this image
No alt text provided for this image

PODCAST:

Accelerating Pediatric Drug Development: Regulatory and Industry Perspectives. In this episode?of Becker’s Hospital Review, we are joined by Patrick Smith, PharmD, President, Integrated Drug Development, Certara and Lynne Yao, MD, Director, Division of Pediatric and Maternal Health, US FDA. They give us an overview of the pediatric drug development landscape, model-informed drug development, share best practices, and more. Listen here.

No alt text provided for this image
No alt text provided for this image

WHITEPAPER:

Advancing Pediatric Drug Development and Regulatory Acceptance Using Simcyp PBPK: from Birth to Young Adult.?Read case studies ranging from?dose selection and neonate exposure to DDI for pediatrics and developing child-specific formulations. Read more.

No alt text provided for this image
No alt text provided for this image

ON-DEMAND WEBINAR:

This webinar discusses a recently developed online patient engagement portal to enable patients to provide direct feedback on PLS. We also focus on the pediatric PLS space, with consideration given to the cognitive development and unique needs and perceptions of children and young people. Watch here.

No alt text provided for this image
No alt text provided for this image

Where is Certara this month?????

Conferences

Webinars

No alt text provided for this image

Enjoying the Inner Circle? Don't forget to subscribe at the top.??

Want to share? Click share below.

Have questions about our services and software? Contact us

No alt text provided for this image

About Certara

Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions, and regulatory agencies across 62 countries.

Corporate Headquarters: 100 Overlook Center, Suite 101, Princeton, NJ 08540 USA

要查看或添加评论,请登录

Certara的更多文章

社区洞察

其他会员也浏览了